Patients with stage IV metastatic non-small cell lung cancer (NSCLC) are generally believed
to have an incurable disease. Patients with oligometastatic disease represent a distinct …

Background The concept of oligometastatic disease (OMD) has expanded the scope of
potentially curative therapy for metastatic NSCLC. However, large uncertainties remain …

Introduction: Many patients with oncogene-driven non–small-cell lung cancer (NSCLC)
treated with tyrosine kinase inhibitors experience limited sites of disease progression. This …

Purpose Population-based estimates of the incidence of brain metastases are not generally
available. The purpose of this study was to calculate population-based incidence …

Background This guideline updates the second edition and addresses patients with
particular forms of non-small cell lung cancer that require special considerations, including …

Background The prognosis of patients with brain metastases from non-small-cell lung
cancer (nsclc) is poor. However, some reports suggest that patients with brain metastases at …

BACKGROUND: A subset of patients with metastatic cancer in limited organs may benefit
from metastasis‐directed therapy. The authors investigated whether patients with limited …

Metastatic cancer to the brain has a poor prognosis. The focus of this work was to determine
the incidence of long-term (≥ 2 y) survival for patients with brain metastases from different …

BACKGROUND The objective of this study was to estimate the incidence and describe
distribution, clinical presentation, and prognosis of brain metastases in patients with …

Object The goal of this study was to evaluate the therapeutic impact of the resection of
metastatic brain tumor cells infiltrating adjacent brain parenchyma. Methods Between July …